만성 기침에 대한 이해 : 신경성 기침을 중심으로
Understanding Chronic Cough : Focused on Neurogenic Cough
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Cough is a protective response of the body, and it is one of the most common clinical symptoms of otorhinolar- yngology. A chronic cough lasting more than 8 weeks is not uncommon and reduces the quality of life of the patient. Causes of chronic cough include lung diseases such as eosinophilic bronchitis, asthma, and cough vari- ant asthma. And otolaryngologic diseases such as laryngopharyngeal reflux disease or upper airway cough syn- drome also cause chronic cough. If chronic cough persists, attention should be paid to laryngopharyngeal reflux disease and upper airway cough syndrome in the view of otorhinolaryngologic aspect. Neurogenic cough should be considered when a cough is induced in a small stimulus with a previous history of upper airway in- fection and lasts longer than 8 weeks. This study aims to summarize the current knowledge on the pathogenesis, clinical symptoms and treatment of neurogenic cough.
Abstract
Cough is a protective response of the body, and it is one of the most common clinical symptoms of otorhinolar- yngology. A chronic cough lasting more than 8 weeks is not uncommon and reduces the quality of life of the patient. Causes of chronic cough include lung diseases such as eosinophilic bronchitis, asthma, and cough vari- ant asthma. And otolaryngologic diseases such as laryngopharyngeal reflux disease or upper airway cough syn- drome also cause chronic cough. If chronic cough persists, attention should be paid to laryngopharyngeal reflux disease and upper airway cough syndrome in the view of otorhinolaryngologic aspect. Neurogenic cough should be considered when a cough is induced in a small stimulus with a previous history of upper airway in- fection and lasts longer than 8 weeks. This study aims to summarize the current knowledge on the pathogenesis, clinical symptoms and treatment of neurogenic cough.
참고문헌 (47)
- Chung KF, "Prevalence, pathogenesis, and causes of chronic cough", Lancet, 371(9621), pp.1364~1374 (2008)
- Barbee RA, "A longitudinal study of respiratory symptoms in a community population sample: correlations with smoking, allergen skin-test reactivity, and serum IgE", Chest, 99(1), pp.20~26 (1991)
- Cullinan P, "Persistent cough and sputum: prevalence and clinical characteristics in south east England", Respir Med, 86(2), pp.143~149 (1992)
- Niimi A, "Geography and cough aetiology", Pulm Pharmacol Ther, 20(4), pp.383~387 (2007)
- Morice AH, "Epidemiology of cough", Pulm Pharmacol Ther, 15(3), pp.253~259 (2002)
- Kiljander TO, "Chronic cough and gastro-oesophageal reflux: a double-blind placebo-controlled study with omeprazole", Eur Respir J, 16(4), pp.633~638 (2000)
- Smith JA, "The oesophagus and cough:laryngo-pharyngeal reflux, microaspiration and vagal reflexes", Cough, 9(1), pp.12~ (2013)
- Kollarik M, "Cough and gastroesophageal reflux: insights from animal models", Pulm Pharmacol Ther, 22(2), pp.130~134 (2009)
- Irwin RS, "Diagnosis and treatment of chronic cough due to gastro-esophageal reflux disease and postnasal drip syndrome", Pulm Pharmacol Ther, 15(3), pp.261~266 (2002)
- Faruqi S, "Chronic cough and esomeprazole: a doubleblind placebo-controlled parallel study", Respirology, 16(7), pp.1150~1156 (2011)
- Kahrilas PJ, "Response of chronic cough to acid-suppressive therapy in patients with gastroesophageal reflux disease", Chest, 143(3), pp.605~612 (2013)
- 송대진, "KAAACI Evidence-Based Clinical Practice Guidelines for Chronic Cough in Adults and Children in Korea", Allergy, Asthma & Immunology Research, 10(6), pp.591~613 (2018), 대한천식알레르기학회
- Chung KF, "American college of chest physicians’ cough guidelines", Lancet, 367(9515), pp.981~982 (2006)
- Morice AH, "Post-nasal drip syndrome-a symptom to be sniffed at?", Pulm Pharmacol Ther, 17(6), pp.343~345 (2004)
- O’Hara J, "“Post-nasal drip syndrome”: most patients with purulent nasal secretions do not complain of chronic cough", Rhinology, 44(4), pp.270~273 (2006)
- Athanasiadis T, "Chronic cough: an otorhinolaryngology perspective", Curr Opin Otolaryngol Head Neck Surg, 21(6), pp.517~522 (2013)
- Lee B, "Chronic cough as a sign of laryngeal sensory neuropathy: diagnosis and treatment", Ann Otol Rhinol Laryngol, 114(4), pp.253~257 (2005)
- Rees CJ, "Postviral vagal neuropathy", Ann Otol Rhinol Laryngol, 118(4), pp.247~252 (2009)
- Amin MR, "Vagal neuropathy after upper respiratory infection: a viral etiology?", Am J Otolaryngol, 22(4), pp.251~256 (2001)
- Greene SM, "Evidence for sensory neuropathy and pharmacologic management", Otolaryngol Clin North Am, 43(1), pp.67~72 (2010)
- Morrison M, "The irritable larynx syndrome", J Voice, 13(3), pp.447~455 (1999)
- Altman KW, "Neurogenic cough", Laryngoscope, 125(7), pp.1675~1681 (2015)
- Canning BJ, "Anatomy and neurophysiology of cough: CHEST Guideline and Expert Panel report", Chest, 146(6), pp.1633~1648 (2014)
- Nilius B, "Transient receptor potential cation channels in disease", Physiological Reviews, 87(1), pp.165~217 (2007)
- Groneberg DA, "Increased expression of transient receptor potential vanilloid-1 in airway nerves of chronic cough", Am J Respir Crit Care Med, 170(12), pp.1276~1280 (2004)
- Zalvan C, "Trigger reduction prior to systemic drugs for neurogenic chronic cough", Laryngoscope, 129(1), pp.198~202 (2019)
- Wang K, "Cough management in primary, secondary and tertiary settings", Pulm Pharmacol Ther, 47(12), pp.93~98 (2017)
- Davenport PW, "Urge-to-cough: what can it teach us about cough?", Lung, 186(Supp 1), pp.S107~S111 (2008)
- Simpson CB, "Chronic cough: state-of-the-art review", Otolaryngol Head Neck Surg, 134(4), pp.693~700 (2006)
- Giliberto JP, "Unilateral laryngoscopic findings associated with response to gabapentin in patients with chronic cough", JAMA Otolaryngol Head Neck Surg, 143(11), pp.1081~1085 (2017)
- Bock JM, "Surface-evoked laryngeal sensory action potential evaluation in neurogenic chronic cough", J Voice, 28(5), pp.624~630 (2014)
- Vertigan AE, "Pregabalin and speech pathology combination therapy for refractory chronic cough: a randomized controlled trial", Chest, 149(3), pp.639~648 (2016)
- Soni RS, "Use of specific neuromodulators in the treatment of chronic, idiopathic cough: a systematic review", Otolaryngol Head Neck Surg, 148(3), pp.374~382 (2013)
- Ryan NM, "Gabapentin for refractory chronic cough: a randomised, double-blind, placebocontrolled trial", Lancet, 380(9853), pp.1583~1589 (2012)
- Ryan NM, "An update and systematic review on drug therapies for the treatment of refractory chronic cough", Expert opinion on pharmacotherapy, 19(7), pp.687~711 (2018)
- Jeyakumar A, "Effectiveness of amitriptyline versus cough suppressants in the treatment of chronic cough resulting from postviral vagal neuropathy", Laryngoscope, 116(12), pp.2108~2112 (2006)
- Bastian RW, "Sensory neuropathic cough: a common and treatable cause of chronic cough", Otolaryngol Head Neck Surg, 135(1), pp.17~21 (2006)
- Norris BK, "Management of recurrent laryngeal sensory neuropathic symptoms", Ann Otol Rhinol Laryngol, 119(3), pp.188~191 (2010)
- Ryan MA, "Long-term follow-up of amitriptyline treatment for idiopathic cough", Laryngoscope, 126(12), pp.2758~2763 (2016)
- Gibson P, "Treatment of unexplained chronic cough: CHEST guideline and expert panel report", Chest, 149(1), pp.27~44 (2016)
- Mintz S, "Gabapentin in the treatment of intractable idiopathic chronic cough", Am J Med, 119(5), pp.e13~e15 (2006)
- Halum SL, "A new treatment option for laryngeal sensory neuropathy", Laryngoscope, 119(9), pp.1844~1847 (2009)
- Cohen SM, "Use of specific neuromodulators in the treatment of chronic, idiopathic cough: a systematic review", Otolaryngol Head Neck Surg, 148(3), pp.374~382 (2013)
- Gibson PG, "Gabapentin in chronic cough", Pulm Pharmacol Ther, 35, pp.145~148 (2015)
- Giliberto JP, "Are neuromodulating medications effective for the treatment of chronic neurogenic cough?", Laryngoscope, 127(5), pp.1007~1008 (2017)
- Simpson CB, "Treatment of chronic neurogenic cough with in-office superior laryngeal nerve block", Laryngoscope, 128(8), pp.1898~1903 (2018)
- Sasieta HC, "Bilateral thyroarytenoid botulinum toxin Type A injection for the treatment of refractory chronic cough", JAMA Otolaryngol Head Neck Surg, 142(9), pp.881~888 (2016)